1. Home
  2. INKT
  3. INKT News

Latest MiNK Therapeutics Inc. (INKT) News on July 26, 2024

MiNK Therapeutics, Inc. (INKT) Upgraded to Strong Buy: Here's What You Should Know
INKT

Zacks

15 days ago

MiNK Therapeutics, Inc. (INKT) Upgraded to Strong Buy: Here's What You Should Know

MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
INKT

GlobeNewswire

2 months ago

MiNK Therapeutics Announces Virtual Annual Shareholders Meeting

MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting
INKT

GlobeNewswire

2 months ago

MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting

INKT

GuruFocus.com

2 months ago

MiNK Therapeutics Inc (INKT) Q1 2024 Earnings Call Transcript Highlights: Strategic Reductions ...

MiNK Reports First Quarter 2024 Results
INKT

GlobeNewswire

2 months ago

MiNK Reports First Quarter 2024 Results

MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer
INKT

GlobeNewswire

2 months ago

MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer

MiNK to Provide Corporate Update and First Quarter 2024 Financial Report
INKT

GlobeNewswire

3 months ago

MiNK to Provide Corporate Update and First Quarter 2024 Financial Report

This MiNK Therapeutics Insider Increased Their Holding In The Last Year
INKT

Simply Wall St.

3 months ago

This MiNK Therapeutics Insider Increased Their Holding In The Last Year

MiNK Therapeutics Announces Promising Preclinical Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR
INKT

GlobeNewswire

4 months ago

MiNK Therapeutics Announces Promising Preclinical Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR

All You Need to Know About MiNK Therapeutics, Inc. (INKT) Rating Upgrade to Buy
INKT

Zacks

4 months ago

All You Need to Know About MiNK Therapeutics, Inc. (INKT) Rating Upgrade to Buy

MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2023 Earnings Call Transcript
INKT

Insider Monkey

4 months ago

MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2023 Earnings Call Transcript

INKT

Thomson Reuters StreetEvents

4 months ago

Q4 2023 Mink Therapeutics Inc Earnings Call

MiNK Reports Fourth Quarter and Year-End 2023 Results
INKT

GlobeNewswire

4 months ago

MiNK Reports Fourth Quarter and Year-End 2023 Results

MiNK to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report
INKT

GlobeNewswire

5 months ago

MiNK to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report

MiNK Announces Preclinical Data Showcasing Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR 2024
INKT

GlobeNewswire

5 months ago

MiNK Announces Preclinical Data Showcasing Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR 2024

First Refractory Gastric Cancer Patient Dosed in Phase 2 Trial with Novel Combination of MiNK’s Allogeneic INKT Cell Therapy and Agenus’ Botensilimab and Balstilimab
INKT

GlobeNewswire

5 months ago

First Refractory Gastric Cancer Patient Dosed in Phase 2 Trial with Novel Combination of MiNK’s Allogeneic INKT Cell Therapy and Agenus’ Botensilimab and Balstilimab

MiNK Therapeutics' AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress, Published in Nature Communications
INKT

GlobeNewswire

6 months ago

MiNK Therapeutics' AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress, Published in Nature Communications

INKT

ACCESSWIRE

6 months ago

Nocturne Acquisition Corporation Announces Postponement of Extraordinary General Meeting

MiNK’s AgenT-797 Offers New Hope in Overcoming ICI Resistance in PD-1 Refractory Gastric Cancer - Published in Oncogene
INKT

GlobeNewswire

6 months ago

MiNK’s AgenT-797 Offers New Hope in Overcoming ICI Resistance in PD-1 Refractory Gastric Cancer - Published in Oncogene

Invesco Closed-End Funds Declare Dividends
INKT

PR Newswire

6 months ago

Invesco Closed-End Funds Declare Dividends

BCB Bancorp, Inc. (NASDAQ:BCBP) most popular amongst retail investors who own 51% of the shares, institutions hold 36%
INKT

Simply Wall St.

6 months ago

BCB Bancorp, Inc. (NASDAQ:BCBP) most popular amongst retail investors who own 51% of the shares, institutions hold 36%

Broadwind (NASDAQ:BWEN) Shareholders Will Want The ROCE Trajectory To Continue
INKT

Simply Wall St.

6 months ago

Broadwind (NASDAQ:BWEN) Shareholders Will Want The ROCE Trajectory To Continue

Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
INKT

GlobeNewswire

6 months ago

Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update
INKT

Zacks

6 months ago

Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update

Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida
INKT

GlobeNewswire

6 months ago

Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida

We're Keeping An Eye On International Tower Hill Mines' (TSE:ITH) Cash Burn Rate
INKT

Simply Wall St.

6 months ago

We're Keeping An Eye On International Tower Hill Mines' (TSE:ITH) Cash Burn Rate

A2Z Smart Technologies Closes Previously Announced US$4.7 Million Registered Direct Offerings, Inclusive of $1.5 Million Raised in December 2023
INKT

ACCESSWIRE

6 months ago

A2Z Smart Technologies Closes Previously Announced US$4.7 Million Registered Direct Offerings, Inclusive of $1.5 Million Raised in December 2023

4 Electronics Semiconductor Stocks to Escape Macro Headwinds
INKT

Zacks

7 months ago

4 Electronics Semiconductor Stocks to Escape Macro Headwinds

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
INKT

PR Newswire

7 months ago

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development
INKT

GlobeNewswire

7 months ago

ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development

Compugen (NASDAQ:CGEN) delivers shareholders impressive 144% return over 1 year, surging 158% in the last week alone
INKT

Simply Wall St.

7 months ago

Compugen (NASDAQ:CGEN) delivers shareholders impressive 144% return over 1 year, surging 158% in the last week alone

With 61% ownership of the shares, Lincoln Educational Services Corporation (NASDAQ:LINC) is heavily dominated by institutional owners
INKT

Simply Wall St.

7 months ago

With 61% ownership of the shares, Lincoln Educational Services Corporation (NASDAQ:LINC) is heavily dominated by institutional owners

Life Science Investor Forum: Presentations Now Available for Online Viewing
INKT

GlobeNewswire

7 months ago

Life Science Investor Forum: Presentations Now Available for Online Viewing

7 Promising Penny Stocks With the Potential to Defy Expectations
INKT

InvestorPlace

7 months ago

7 Promising Penny Stocks With the Potential to Defy Expectations

What Makes Corvus (CRVS) a New Buy Stock
INKT

Zacks

8 months ago

What Makes Corvus (CRVS) a New Buy Stock

Here's Why We're Not Too Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Situation
INKT

Simply Wall St.

8 months ago

Here's Why We're Not Too Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Situation

GreenPower Panel Shares Real-World Experiences from Deploying the Type A Nano BEAST in Special Needs Situations
INKT

CNW Group

8 months ago

GreenPower Panel Shares Real-World Experiences from Deploying the Type A Nano BEAST in Special Needs Situations

Purple Announces Positive Black Friday/Cyber Monday Weekend Selling Period and Reiterates 2023 Full Year Outlook Ahead of Investor Conferences
INKT

PR Newswire

8 months ago

Purple Announces Positive Black Friday/Cyber Monday Weekend Selling Period and Reiterates 2023 Full Year Outlook Ahead of Investor Conferences

Is It Too Late To Consider Buying Live Ventures Incorporated (NASDAQ:LIVE)?
INKT

Simply Wall St.

8 months ago

Is It Too Late To Consider Buying Live Ventures Incorporated (NASDAQ:LIVE)?

GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy
INKT

GlobeNewswire

8 months ago

GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy

Positive Signs As Multiple Insiders Buy Investar Holding Stock
INKT

Simply Wall St.

8 months ago

Positive Signs As Multiple Insiders Buy Investar Holding Stock

TeraWulf Inc. (NASDAQ:WULF) Analysts Just Slashed Next Year's Estimates
INKT

Simply Wall St.

8 months ago

TeraWulf Inc. (NASDAQ:WULF) Analysts Just Slashed Next Year's Estimates

Inogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO
INKT

Business Wire

8 months ago

Inogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO

FitLife Brands Announces Third Quarter 2023 Results
INKT

GlobeNewswire

8 months ago

FitLife Brands Announces Third Quarter 2023 Results

Sagimet Biosciences Presents Preclinical Results Supporting the Therapeutic Potential of its FASN inhibitor in Combination with Semaglutide and a Comprehensive Lipidomic Analysis of Interim FASCINATE-2 Data at AASLD - The Liver Meeting® 2023
INKT

GlobeNewswire

9 months ago

Sagimet Biosciences Presents Preclinical Results Supporting the Therapeutic Potential of its FASN inhibitor in Combination with Semaglutide and a Comprehensive Lipidomic Analysis of Interim FASCINATE-2 Data at AASLD - The Liver Meeting® 2023

Aqua Metals, Inc. (NASDAQ:AQMS) Q3 2023 Earnings Call Transcript
INKT

Insider Monkey

9 months ago

Aqua Metals, Inc. (NASDAQ:AQMS) Q3 2023 Earnings Call Transcript

INKT

GuruFocus.com

9 months ago

MiNK Therapeutics Inc (INKT) Reports Q3 2023 Results: Clinical Progress Amid Financial Challenges

MiNK Therapeutics Reports Third Quarter 2023 Results
INKT

GlobeNewswire

9 months ago

MiNK Therapeutics Reports Third Quarter 2023 Results

Full House Resorts Announces Strong Third Quarter Results
INKT

GlobeNewswire

9 months ago

Full House Resorts Announces Strong Third Quarter Results

SHL Telemedicine Establishes US Nationwide Cardiology Network for ECG Interpretations and Telehealth Visits
INKT

Business Wire

9 months ago

SHL Telemedicine Establishes US Nationwide Cardiology Network for ECG Interpretations and Telehealth Visits

Meridian (NASDAQ:MRBK) Could Be A Buy For Its Upcoming Dividend
INKT

Simply Wall St.

9 months ago

Meridian (NASDAQ:MRBK) Could Be A Buy For Its Upcoming Dividend

Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)
INKT

PR Newswire

9 months ago

Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)

Share on Social Networks: